Seeking Alpha

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the...

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the company receiving FDA approval for weight-loss drug Belviq by promoting him to Senior VP, Operations and Head of Global Regulatory Affairs. Audet's new role will also include investor relations and alliance management. (PR)
From other sites
Comments (3)
  • MexCom
    , contributor
    Comments (3067) | Send Message
     
    Leadership and ability is worth more than gold.
    5 Jul 2012, 10:24 AM Reply Like
  • WLNieder
    , contributor
    Comments (4) | Send Message
     
    I looked up his bio and it is outstanding.
    5 Jul 2012, 11:58 AM Reply Like
  • Day Trader001
    , contributor
    Comments (817) | Send Message
     
    "Perfect Choice" !!!!!!
    5 Jul 2012, 03:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs